Download
1-s2.0-S2211383520305499-main.pdf 1,65MB
WeightNameValue
1000 Titel
  • D3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19
1000 Autor/in
  1. Shi, Yulong |
  2. Zhang, Xinben |
  3. Mu, Kaijie |
  4. Peng, Cheng |
  5. Zhu, Zhengdan |
  6. Wang, Xiaoyu |
  7. Yang, Yanqing |
  8. Xu, Zhijian |
  9. Zhu, Weiliang |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-04-20
1000 Erschienen in
1000 Quellenangabe
  • 10(7):1239-1248
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1016/j.apsb.2020.04.006 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169934/ |
1000 Ergänzendes Material
  • https://www.sciencedirect.com/science/article/pii/S2211383520305499#appsec1 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • A highly effective medicine is urgently required to cure coronavirus disease 2019 (COVID-19). For the purpose, we developed a molecular docking based webserver, namely D3Targets-2019-nCoV, with two functions, one is for predicting drug targets for drugs or active compounds observed from clinic or in vitro/in vivo studies, the other is for identifying lead compounds against potential drug targets via docking. This server has its unique features, (1) the potential target proteins and their different conformations involving in the whole process from virus infection to replication and release were included as many as possible; (2) all the potential ligand-binding sites with volume larger than 200 Å3 on a protein structure were identified for docking; (3) correlation information among some conformations or binding sites was annotated; (4) it is easy to be updated, and is accessible freely to public (https://www.d3pharma.com/D3Targets-2019-nCoV/index.php). Currently, the webserver contains 42 proteins [20 severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) encoded proteins and 22 human proteins involved in virus infection, replication and release] with 69 different conformations/structures and 557 potential ligand-binding pockets in total. With 6 examples, we demonstrated that the webserver should be useful to medicinal chemists, pharmacologists and clinicians for efficiently discovering or developing effective drugs against the SARS-CoV-2 to cure COVID-19.
1000 Sacherschließung
lokal DockingD3Targets-2019-nCoV
gnd 1206347392 COVID-19
lokal Multi-site
lokal Multi-conformation
lokal Target prediction
lokal SARS-CoV-2
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U2hpLCBZdWxvbmc=|https://frl.publisso.de/adhoc/uri/WmhhbmcsIFhpbmJlbg==|https://frl.publisso.de/adhoc/uri/TXUsIEthaWppZQ==|https://frl.publisso.de/adhoc/uri/UGVuZywgQ2hlbmc=|https://frl.publisso.de/adhoc/uri/Wmh1LCBaaGVuZ2Rhbg==|https://frl.publisso.de/adhoc/uri/V2FuZywgWGlhb3l1|https://frl.publisso.de/adhoc/uri/WWFuZywgWWFucWluZw==|https://frl.publisso.de/adhoc/uri/WHUsIFpoaWppYW4=|https://frl.publisso.de/adhoc/uri/Wmh1LCBXZWlsaWFuZw==
1000 Label
1000 Förderer
  1. National Basic Research Program of China (973 Program) |
1000 Fördernummer
  1. 2017YFB0202601; 2016YFA0502301
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer National Basic Research Program of China (973 Program) |
    1000 Förderprogramm -
    1000 Fördernummer 2017YFB0202601; 2016YFA0502301
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6422808.rdf
1000 Erstellt am 2020-08-28T08:58:16.872+0200
1000 Erstellt von 21
1000 beschreibt frl:6422808
1000 Bearbeitet von 21
1000 Zuletzt bearbeitet Fri Aug 28 08:59:30 CEST 2020
1000 Objekt bearb. Fri Aug 28 08:59:13 CEST 2020
1000 Vgl. frl:6422808
1000 Oai Id
  1. oai:frl.publisso.de:frl:6422808 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source